United States · Exchanges & live quotes · Nasdaq

Cerenome Unit Signs National Reimbursement Agreement With Aetna; Shares Fall

Published by Nasdaq · United States 2 h ago

(RTTNews) - Biotechnology company Cerenome, Inc. (CNSY) announced on Wednesday that its CNSide Diagnostics unit has entered into a national in-network laboratory provider…

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading

OilPrice.com

Oil Crashes 9% as Trump and Vance Blame Iran War for Midterm Rout

Investopedia

Big Tech Rallies, Defense and Prison Stocks Sink: Here’s What’s Moving After the Democrats’ Sweep

CNN Markets

Cerenome Unit Signs National Reimbursement Agreement With Aetna; Shares Fall

Share

Also worth reading

Oil Crashes 9% as Trump and Vance Blame Iran War for Midterm Rout

Big Tech Rallies, Defense and Prison Stocks Sink: Here’s What’s Moving After the Democrats’ Sweep

Do you use AI agents to run your daily life? We want to hear about it

Stellar (XLM) Rises 3.6% Amid Crypto Market Rebound

Cboe FLEX Options Hit Record Volume in Q3 2026

New capabilities to power agents at scale with Google's Agentic Data Cloud